autologous dendritic cell vaccine (Malaghan Institute of Medical Research)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameautologous dendritic cell vaccine (Malaghan Institute of Medical Research)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapyVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew Zealand

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesThe Malaghan Institute Of Medical Research

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe Malaghan Institute Of Medical Research

Active IndicationsN/A

Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A